Mice with overexpression of IL-23 represented axial and peripheral enthesitis, and entheseal new bone formation, which is similar to human AS; blockade of the downstream effector cytokine IL-17 significantly reduced disease [52]. The gene discussed is IL23A; the disease is enthesitis.